Recall of reactive cutaneous capillary endothelial proliferation (RCCEP) induced by stereotactic body radiation therapy (SBRT) in a patient with lung squamous cell carcinoma

Camrelizumab (SHR-1210) is a humanized IgG4 monoclonal anti-programmed cell death protein 1 (PD-1) antibody that has been shown to inhibit the binding of PD-1 to PD-L1, thereby blocking the immune escape of various types of cancer, including lung squamous cell carcinoma (LSCC). Reactive cutaneous ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Rong, Wang, Jia-Lin, Wang, Yan-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607856/
https://www.ncbi.nlm.nih.gov/pubmed/36289520
http://dx.doi.org/10.1186/s40164-022-00336-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607856/
https://www.ncbi.nlm.nih.gov/pubmed/36289520
http://dx.doi.org/10.1186/s40164-022-00336-4

Ejemplares similares